Staging of brain pathology related to sporadic Parkinson's disease.
Level 4 - case-series / case-control
Post-mortem neuropathological case series proposing a pathological staging scheme.
PubMed 12498954 · doi:10.1016/s0197-4580(02)00065-9
What was done
The authors analyzed post-mortem brain tissue from incidental and symptomatic sporadic Parkinson's disease cases using alpha-synuclein immunohistochemistry (identifying Lewy bodies and Lewy neurites) to trace the anatomical distribution of pathology and develop a neuropathological staging system.
What was found
The abstract reports no numerical data or case counts. Qualitatively, pathology initially appears in the dorsal motor nucleus of the glossopharyngeal and vagal nerves as well as the anterior olfactory nucleus. The disease follows an ascending brainstem trajectory with minimal interindividual variation, subsequently advancing into the anteromedial temporal mesocortex, high-order sensory association and prefrontal neocortical regions, and finally first-order sensory association, premotor, and primary sensory/motor cortices.
Why it matters
This study introduced the Braak staging model of sporadic Parkinson's disease, proposing that alpha-synuclein pathology progresses along a stereotypical anatomical pathway starting outside the substantia nigra in the lower brainstem and olfactory structures before ascending to the cerebral cortex.
Limits
The abstract does not disclose the sample size, patient demographics, clinical characteristics, or any quantitative metrics. In addition, the chronological staging model is inferred from cross-sectional post-mortem evaluations rather than direct longitudinal observation.
Cited by
- supports In 2003, Dr. Heiko Braak proposed that misfolded protein pathology in Parkinson's disease propagates progressively from nerve cell to nerve cell.